Gerresheimer AG's EPS (Basic) for the
three
months ended in Aug. 2025 was CHF-0.35.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Aug. 2025 was CHF0.63.
During the past 12 months, Gerresheimer AG's average EPS without NRIGrowth Rate was -79.60% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 3.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, Gerresheimer AG's highest 3-Year average EPS without NRI Growth Rate was 116.80% per year. The lowest was -12.30% per year. And the median was 15.60% per year.
Gerresheimer AG (XSWX:GXI) EPS (Diluted) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Gerresheimer AG EPS (Diluted) Related Terms
Gerresheimer AG EPS (Diluted) Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:GXI vs ISRG, BDX, MDLN: EPS (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PE Ratio distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
Gerresheimer AG's Diluted EPS for the fiscal year that ended in Nov. 2024 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Aug. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.63
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG (XSWX:GXI) has a EPS (Diluted) of CHF0.63 as of Aug. 2025. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Gerresheimer AG and its competitors.
Is Gerresheimer AG's EPS (Diluted) too high?
Gerresheimer AG's current EPS (Diluted) is CHF0.63. Overall, Gerresheimer AG has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's EPS (Diluted) compare to ISRG and BDX?
Gerresheimer AG's EPS (Diluted) of CHF0.63 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Devices & Instruments company?
A good EPS (Diluted) depends on the Medical Devices & Instruments industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on Gerresheimer AG and its competitors. Gerresheimer AG's current EPS (Diluted) is CHF0.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (XSWX:GXI) is currently considered Possible Value Trap. The stock's GF Value™ is CHF87.96, compared to a current price of CHF25.02 — trading 71.6% below its estimated fair value. The current EPS (Diluted) is CHF0.63. Gerresheimer AG's overall GF Score™ is 73/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For Gerresheimer AG (XSWX:GXI), the current EPS (Diluted) is CHF0.63 as of Aug. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (XSWX:GXI) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of CHF25.02 is trading 71.6% below its estimated GF Value™ of CHF87.96.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for XSWX:GXI:
EPS (Diluted): CHF0.63
GF Value™: CHF87.96 vs. price of CHF25.02 (71.6% below fair value)
No single metric tells the full story. See the XSWX:GXI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
73GF Score
Get the complete analysis for XSWX:GXI
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:GXI has been successfully added to your 
